SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending following its strong earnings report and optimistic guidance driven by AI and data center growth. However, community discussion is sharply divided, with many anticipating a typical 'sell the news' reaction and attributing the muted price action to options market dynamics.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending following its Q4 earnings beat, overshadowed by weaker Q1 revenue guidance that triggered a sharp stock decline. The community is deeply divided, with many believing the sell-off is an overreaction and buying the dip, while others are vocal about management concerns and expect further declines amidst competitive ad-tech pressures.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is a major talking point after reporting strong quarterly results and announcing a significant share repurchase program and dividend increase, yet the stock's market reaction has intensified community debate between those who see deep value and AI-driven growth against an overblown "software apocalypse" narrative, and others who remain concerned about AI's disruptive impact on traditional SaaS.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is actively discussed after reporting strong financial results and optimistic guidance, further buoyed by a key defense contract and the SkyWater acquisition, which has prompted widespread bullish sentiment and expectations of a short squeeze despite counterarguments from critics citing alleged revenue misrepresentation and ongoing losses within the highly speculative quantum computing sector.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is trending due to reports of potential merger talks with private firm Automation Anywhere, which could take the automation company public through the deal. This follows a disappointing earnings report and weak guidance, leading to community debate over whether it's a lifeline for the underperforming AI stock or further evidence of its struggles.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending after its mixed earnings report, where an EPS beat and early demand for smart eyewear are overshadowed by persistent delays in smartphone qualification with its lead customer Honor, sparking a community debate over long-term execution and manufacturing yields.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending following its recent earnings report, which showcased robust revenue and a strong cash position, alongside the announcement of CEO Doug Ingram's planned retirement by the end of 2026. This leadership change is fueling extensive community speculation about a potential buyout and highlighting the stock's significant undervaluation relative to its commercial gene therapy and expansive RNAi pipeline in rare diseases.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

LRMR's nomlabofusp received FDA Breakthrough Therapy Designation for Friedreich's ataxia, sparking strong bullish sentiment over its market potential and fueling short squeeze discussions. However, a concurrent public offering has generated community debate regarding immediate dilution impacts.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Bozeman, MT.

Snowflake Inc

Snowflake Inc. is trending after reporting strong Q4 performance but providing forward guidance that projects a slowdown in product revenue growth. This has sparked community discussions regarding the company's ability to monetize AI adoption and whether concerns about AI disruption in the broader software sector are justified for its data platform.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in George Town, Cayman Islands.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is trending after delivering strong Q4 earnings that exceeded expectations, showcasing record revenues and profitability. However, community sentiment is mixed, as many express frustration over the stock's typical post-earnings pullback despite the positive financial performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ArriVent BioPharma (AVBP) Projected to Post Earnings on Monday

ArriVent BioPharma (NASDAQ:AVBP) will be releasing its Q4 2025 earnings before the market opens on Monday, March 2. (View Earnings Report at...

ArriVent BioPharma (NASDAQ:AVBP) Trading Up 6.8% - Still a Buy?

ArriVent BioPharma (NASDAQ:AVBP) Stock Price Up 6.8% - What's Next...

EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034)  DelveInsight

EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast...

ArriVent BioPharma (NASDAQ:AVBP) Shares Down 5.6% - Here's Why

ArriVent BioPharma (NASDAQ:AVBP) Stock Price Down 5.6% - Here's Why...

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Receives Consensus Rating of "Moderate Buy" from Analysts

ArriVent BioPharma, Inc. (NASDAQ:AVBP - Get Free Report) has been given a consensus rating of "Moderate Buy" by the twelve ratings firms that are currently covering the stock, Marketbeat Ratings...

$207B Market Shift: The Race for Fast Track Approval in Oncology

$207B Market Shift: The Race for Fast Track Approval in Oncology $207B Market Shift: The Race for Fast Track Approval in Oncology PR Newswire VANCOUVER, BC, Feb. 5, 2026 Issued on behalf of...

ArriVent BioPharma (NASDAQ:AVBP) Trading Down 5.8% - Here's What Happened

ArriVent BioPharma (NASDAQ:AVBP) Shares Down 5.8% - Should You Sell...

ArriVent BioPharma (NASDAQ:AVBP) Shares Up 8.2% - What's Next?

ArriVent BioPharma (NASDAQ:AVBP) Shares Up 8.2% - What's Next...

ArriVent BioPharma (NASDAQ:AVBP) Stock Price Down 7.4% - Here's What Happened

ArriVent BioPharma (NASDAQ:AVBP) Trading Down 7.4% - Time to Sell...

ArriVent BioPharma (NASDAQ:AVBP) Trading Down 3.2% - What's Next?

ArriVent BioPharma (NASDAQ:AVBP) Trading Down 3.2% - Time to Sell...

Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.

Current Price	$23.29
Prev Close	$23.30
Open	$23.34
Dividend Yield	0.00%
50-Day Moving Average	$22.10
Beta	0.90
Avg. Volume	417,604.60
PE Ratio	-5.50

52-Week High	$26.33
52-Week Low	$15.47
Market Capitalization	$961.86M
EPS (Annual)	-$2.39
Price to Book	3.12
Revenue Per Employee	$0.00

AVBP
ArriVent BioPharma Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AVBP News

AVBPArriVent BioPharma Inc.